User:Matteo Iannacone

Contact Info

Matteo Iannacone (an artistic interpretation)

• Matteo Iannacone
• San Raffaele Scientific Institute and Harvard Medical School
• Address 1
• Address 2
• City, State, Country etc.
• Email me through OpenWetWare

I work in the Your Lab at XYZ University. I learned about OpenWetWare from I saw one lab website, and I've joined because I'm starting my own lab and would like to set up a lab website.

Education

• Year, PhD, Institute
• Year, MS, Institute
• Year, BS, Institute

Research interests

1. Interest 1
2. Interest 2
3. Interest 3

Publications

1. Iannacone M, Sitia G, and Guidotti LG. On the role of platelets in the pathogenesis of viral hepatitis. J Hepatol. 2009 Sep;51(3):599-600. DOI:10.1016/j.jhep.2009.05.005 |
2. Iannacone M, Sitia G, Isogawa M, Whitmire JK, Marchese P, Chisari FV, Ruggeri ZM, and Guidotti LG. Platelets prevent IFN-alpha/beta-induced lethal hemorrhage promoting CTL-dependent clearance of lymphocytic choriomeningitis virus. Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):629-34. DOI:10.1073/pnas.0711200105 |
3. Junt T, Moseman EA, Iannacone M, Massberg S, Lang PA, Boes M, Fink K, Henrickson SE, Shayakhmetov DM, Di Paolo NC, van Rooijen N, Mempel TR, Whelan SP, and von Andrian UH. Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature. 2007 Nov 1;450(7166):110-4. DOI:10.1038/nature06287 |
4. Iannacone M, Sitia G, Narvaiza I, Ruggeri ZM, and Guidotti LG. Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus. Clin Vaccine Immunol. 2007 Nov;14(11):1532-5. DOI:10.1128/CVI.00298-07 |
5. Nascimbene A, Iannacone M, Brando B, and De Gasperi A. Acute thrombocytopenia after liver transplant: role of platelet activation, thrombopoietin deficiency and response to high dose intravenous IgG treatment. J Hepatol. 2007 Nov;47(5):651-7. DOI:10.1016/j.jhep.2007.06.012 |
6. Iannacone M, Sitia G, Ruggeri ZM, and Guidotti LG. HBV pathogenesis in animal models: recent advances on the role of platelets. J Hepatol. 2007 Apr;46(4):719-26. DOI:10.1016/j.jhep.2007.01.007 |
7. Sitia G, Iannacone M, Müller S, Bianchi ME, and Guidotti LG. Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice. J Leukoc Biol. 2007 Jan;81(1):100-7. DOI:10.1189/jlb.0306173 |
8. Iannacone M, Sitia G, Isogawa M, Marchese P, Castro MG, Lowenstein PR, Chisari FV, Ruggeri ZM, and Guidotti LG. Platelets mediate cytotoxic T lymphocyte-induced liver damage. Nat Med. 2005 Nov;11(11):1167-9. DOI:10.1038/nm1317 |
9. Rovere-Querini P, Capobianco A, Scaffidi P, Valentinis B, Catalanotti F, Giazzon M, Dumitriu IE, Müller S, Iannacone M, Traversari C, Bianchi ME, and Manfredi AA. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 2004 Aug;5(8):825-30. DOI:10.1038/sj.embor.7400205 |
10. Sitia G, Isogawa M, Iannacone M, Campbell IL, Chisari FV, and Guidotti LG. MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs. J Clin Invest. 2004 Apr;113(8):1158-67. DOI:10.1172/JCI21087 |
11. Manfredi AA, Iannacone M, D'Auria F, and Rovere-Querini P. The disposal of dying cells in living tissues. Apoptosis. 2002 Apr;7(2):153-61. DOI:10.1023/a:1014366531885 |
12. Bondanza A, Manfredi AA, Zimmermann VS, Iannacone M, Tincani A, Balestrieri G, Sabbadini MG, and Querini PR. Anti-beta2 glycoprotein I antibodies cause inflammation and recruit dendritic cells in platelet clearance. Thromb Haemost. 2001 Nov;86(5):1257-63.
13. Mauvais-Jarvis F, Ueki K, Fruman DA, Hirshman MF, Sakamoto K, Goodyear LJ, Iannacone M, Accili D, Cantley LC, and Kahn CR. Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes. J Clin Invest. 2002 Jan;109(1):141-9. DOI:10.1172/JCI13305 |

    leave a comment about a paper here

14. ISBN:0879697164

Useful links

• Introductory tutorial
• OpenWetWare help pages